The influence of pharmaceutical company on drug availabilty
From The Embassy of Good Science
Revision as of 21:31, 22 February 2021 by 0000-0003-0487-893X (talk | contribs) (Created page with "{{Theme |Theme Type=Misconduct & Misbehaviors |Has Parent Theme=Theme:6d71bd59-c3bc-4cd5-9c9f-1ab4e53fc320 |Title=The influence of pharmaceutical company on drug availabilty |...")
ThemesThe influence of pharmaceutical company on drug availabilty
What is this about?
Given that the research is sponsored by a pharmaceutical company and that they deliver the drug to Croatia (drug is not available in Croatia), shipments of the drug may be delayed.
Why is this important?
Delayed drug availability may affect research results.
For whom is this important?
Academic staffAuthorsClinical researchersDoctoral studentsMentorsJournal publishersPatientsAdministratorssupport staffResearchersPhD StudentsPrincipal investigatorsEveryone
What are the best practices?
Good organization between the pharmaceutical companies, CRO and clinics where the research takes place.
Marija Pancirov contributed to this theme. Latest contribution was Feb 22, 2021
